The clinical trial industry is literally exploding, launching more trials within shorter windows, adding new players, incorporating new technologies and meeting unprecedented regulatory challenges.

Decentralized trials (DCTs) have grown in acceptance since the COVID pandemic when mobile research nurses were asked to step in and save hundreds of site-based clinical trials that were in jeopardy of being postponed or cancelled because of mandated lockdowns and fear of spreading the virus.